The efficacy of this drug depends on the cell membrane HER2 concentration [39] and allows to decrease the systemic cytotoxic effects of DM1, by its specific delivery to the tumor HER2-overexpression cells [38,39], triggering autophagy and apoptosis [40]. This evidence concerns the gene ERBB2 and neoplasm.